{"id":"NCT02959996","sponsor":"Massachusetts General Hospital","briefTitle":"Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain","officialTitle":"Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-03-08","primaryCompletion":"2017-09-25","completion":"2017-11-03","firstPosted":"2016-11-09","resultsPosted":"2018-08-27","lastUpdate":"2018-08-27"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"Liposomal bupivacaine","otherNames":["Exparel"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Intervention","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.","primaryOutcome":{"measure":"Pain Score With Activity","timeFrame":"at 48-hours post-operatively","effectByArm":[{"arm":"Placebo","deltaMin":3.5,"sd":null},{"arm":"Intervention","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.72"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29889750"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":[]}}